Esperion Therapeutics
ESPR
#6991
Rank
NZ$0.76 B
Marketcap
$3.87
Share price
0.69%
Change (1 day)
3.21%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.63

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.98. In 2022 the company made an earnings per share (EPS) of -$6.27 an increase over its 2021 EPS that were of -$16.89.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.63-26.25%
2022-$6.27-62.87%
2021-$16.8980.38%
2020-$9.3650.14%
2019-$6.24-53.18%
2018-$13.327.41%
2017-$12.40110.81%
2016-$5.8847.35%
2015-$3.990.89%
2014-$3.9628.84%
2013-$3.07-89.3%
2012-$28.71
2002-$12.108.89%
2001-$11.11-83.77%
2000-$68.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$18.09 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.38-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.29-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$66.01-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.13-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.20-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA